NRP1 and CD4+/CD56+ hematodermic neoplasm: A bone marrow aspirate was performed and based on the following immunophenotype: CD123++/CD4+/CD56+/HLA-DR++/CD303+/CD304+/CD45RA++, and a diagnosis of BPDCN was made.